Tu carrito está vacío
Empieza a añadir péptidos de investigación a tu carrito.
TAMBIÉN TE PUEDE INTERESAR
NewTriple Receptor Research Peptide · 2-3-Day Delivery to Edinburgh
A triple receptor agonist (GLP-1 / GIP / Glucagon) investigated in early-phase metabolic research. Studies suggest Retatrutide may modulate appetite, glucose homeostasis, and energy expenditure through three independent incretin pathways. ORYN Retatrutide delivers 5mg/3ml in a reusable pen system with precision dosing for 30 days.
Retatrutide is the most extensively studied tri-incretin compound to date. It activates GLP-1, GIP, and glucagon receptors simultaneously — adding a glucagon-receptor arm to the dual mechanism of Tirzepatide. Early-phase research suggests this triple action may modulate appetite, glucose homeostasis, and energy expenditure through three independent incretin pathways at once.
LOCAL PRICING
From £134 UK · €156 EU · $169 US · R$ 1.300 BR. All prices include customs and shipping within the destination region, no hidden fees at the door.
RESEARCH FOCUS
Retatrutide (LY3437943) is a single-molecule triple agonist that simultaneously activates three incretin and metabolic hormone receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR). This triple mechanism differentiates it from dual agonists like tirzepatide, which target only GIP and GLP-1 receptors. GLP-1R activation suppresses appetite centrally via hypothalamic signalling, slows gastric emp…
LOCAL RESEARCH HUB
Edinburgh is home to active research groups that use peptide pen delivery in their studies. ORYN supplies verified-purity peptides to researchers across the region.
DISPATCH & DELIVERY
ORYN delivers Retatrutide peptide pens directly to Edinburgh with 2-3-day tracked delivery. Order online at orynpeptides.com and receive your pre-mixed, research-grade pen at your door.
ORYN Retatrutide is priced at €169 per pen, which contains a 30-day supply of 5 mg in a pre-mixed, ready-to-use pen system. Free UK delivery on orders over €175.
Yes, Retatrutide is legal to purchase for research purposes in Edinburgh and across the UK. ORYN products are sold strictly for research use only.
ORYN Retatrutide exceeds 99% purity, verified by independent HPLC analysis. Each batch comes with a Certificate of Analysis from a third-party laboratory.
Retatrutide is a triple agonist (GLP-1 + GIP + glucagon receptors) while Tirzepatide is dual (GLP-1 + GIP). Adding glucagon-receptor activation may further increase energy expenditure and lipid mobilisation. Phase-2 trials reported up to 24% body weight reduction vs Tirzepatide's ~22.5%.
5 mg covers a full 30-day dose-titration block at phase-2 schedules: starting at 0.5 mg weekly and escalating in 4-week intervals up to the target research dose.
2-3-daytracked delivery. Pre-mixed & ready to use. >99% purity guaranteed.
ORDER RETATRUTIDE — €169